The medical community is excited by retatrutide, a new dual GIP and GLP-1 receptor that’s showing impressive results in preliminary studies . This treatment works by replicating natural hormones to impact appetite and boost feelings of satiety, ultimately leading substantial body reduction . While still under review and not readily available, in… Read More